SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
SEC Accession No. 0001193125-08-063479
Filing Date
2008-03-24
Accepted
2008-03-24 15:17:07
Documents
6
Period of Report
2008-03-24
Filing Date Changed
2008-03-24

Document Format Files

Seq Description Document Type Size
1 FORM 6-K d6k.htm 6-K 10059
  Complete submission text file 0001193125-08-063479.txt   4029864

Data Files

Seq Description Document Type Size
2 XBRL INSTANCE DOCUMENT teva-20071231.xml EX-100.INS 63148
3 XBRL TAXONOMY EXTENSION SCHEMA teva-20071231.xsd EX-100.SCH 200971
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE teva-20071231_cal.xml EX-100.CAL 945269
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE teva-20071231_lab.xml EX-100.LAB 1216079
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE teva-20071231_pre.xml EX-100.PRE 1592082
Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 5 BAZEL ST PO B 3190 PETACH TIKVA L3 49131
Business Address 5 BAZEL ST P O B 3190 PETACH TIKVA L3 49131
TEVA PHARMACEUTICAL INDUSTRIES LTD (Filer) CIK: 0000818686 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 000-16174 | Film No.: 08706918
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1